Bicycle Therapeutics plc (BCYC)
NASDAQ·Healthcare·Biotechnology
$3.97
+2.45%
Mkt Cap $372.77M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (15 analysts)
$10.67
Range $8.00 – $12.00
Implied Upside
+169.1%
Consensus $10.67 vs current $3.97
NASDAQ·Healthcare·Biotechnology
$3.97
+2.45%
Mkt Cap $372.77M
Buy
2
Hold
1
Sell
0
Price Target (15 analysts)
$10.67
Range $8.00 – $12.00
+169.1%
Consensus $10.67 vs current $3.97